Shilpa Medicare Limited

NSE: SHILPAMED · Healthcare

₹942.35+2.23%06 Nov 2026

Check figures: unusual quarterly results in JUN '26 (₹100.88 cr vs a typical ₹9.56 cr). This may be a filing error (e.g. lakh filed as crore) or a genuine one-off; figures are shown as filed. Trailing-twelve-month figures include it.

Ask the data

Instant answers about Shilpa Medicare Limited — computed from its filings, no language model

Market cap₹18,432 cr

Current price₹942.35

High / Low₹1,074 / ₹267

P/E64.0

P/B6.68

Book value₹141.0

ROE10.4%

ROCE12.5%

Debt / equity0.24

Dividend yield0.05%

EPS (TTM)₹14.72

Face value₹1

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	FY18	FY20	FY22	FY23	FY24	FY25	FY26
Revenue	792	908	1,146	1,050	1,152	1,286	1,539
EBITDA	162	220	204	102	244	317	435
Operating margin	20.5%	24.2%	17.8%	9.7%	21.2%	24.6%	28.2%
Interest	3	5	41	59	92	76	59
Depreciation	37	44	80	96	108	113	120
Profit before tax	144	188	102	-34	59	124	295
Tax	34	33	42	-7	22	44	52
Net profit	104	156	61	-32	0	0	243
EPS ₹	13.20	19.15	7.26	3.74	3.67	8.04	12.44
Operating cash flow	—	—	105	226	135	132	342
Capex	—	—	332	273	185	244	371
Dividend paid	—	—	9	10	0	0	10
Total assets	—	—	—	2,902	3,093	3,311	3,706
Equity	—	—	—	1,783	1,809	2,372	2,591

Quarterly performance

last 31 quarters · ₹ crore

showing latest 8 of 31 periods

	MAR '18	SEP '18	DEC '18	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	234	162	173	290	237	220	223	279	191	237	295	272	341	261	263	262	264	260	313	286	292	293	344	319	331	321	370	410	437	466	529
Operating profit	47	38	26	68	74	46	66	69	21	32	53	45	74	21	12	31	38	48	60	66	70	74	86	81	77	92	108	114	120	136	142
Operating margin	20.2%	23.1%	15.1%	23.5%	31.1%	20.7%	29.5%	24.6%	11.0%	13.4%	18.0%	16.6%	21.6%	7.9%	4.6%	11.9%	14.5%	18.4%	19.3%	23.0%	24.0%	25.2%	25.0%	25.3%	23.2%	28.5%	29.3%	27.9%	27.4%	29.3%	26.9%
Other income	7	3	3	6	3	9	5	9	9	2	1	5	5	8	4	3	2	2	2	2	2	9	5	1	8	6	2	1	2	3	9
Interest	1	1	1	1	1	1	4	4	5	10	12	10	9	10	13	18	18	18	23	26	24	24	26	12	14	19	16	11	14	12	13
Depreciation	11	10	11	11	11	12	12	13	14	18	19	21	22	22	23	24	26	27	28	27	27	27	28	29	29	29	30	30	31	35	34
Profit before tax	42	56	11	62	65	42	116	61	11	6	33	20	46	-3	-20	-8	-3	5	11	15	28	32	37	41	13	50	65	61	120	92	104
Tax	10	11	-0	11	11	8	29	16	3	4	12	10	17	-6	-4	-1	4	2	8	9	3	15	19	10	1	3	20	16	13	-3	24
Net profit	32	45	12	51	55	35	86	0	0	2	20	10	30	1	-19	-7	-8	1	0	0	0	0	0	32	0	0	44	0	108	101	79
EPS ₹	3.94	5.22	1.46	6.23	6.75	4.24	10.59	5.57	0.94	0.19	2.45	1.13	3.40	0.10	-2.15	-0.76	-0.93	0.14	0.19	0.53	2.82	1.46	1.83	3.25	1.48	4.79	2.25	2.36	5.51	5.16	4.05
Revenue YoY	—	—	—	78.7%	36.6%	—	—	-3.8%	-19.3%	6.5%	5.9%	42.4%	—	10.0%	-11.0%	-3.6%	-22.6%	-0.4%	19.0%	9.1%	10.7%	12.4%	9.8%	11.5%	13.4%	9.9%	7.6%	28.3%	32.1%	44.9%	43.0%
Profit YoY	—	—	—	13.5%	341.5%	—	—	-100.0%	-100.0%	-98.2%	—	—	—	-46.5%	-193.5%	-169.2%	-127.2%	38.8%	—	—	—	-100.0%	—	—	—	—	—	-100.0%	—	—	79.7%

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Shilpa Medicare Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	138	234	257	278	328	527	565	676	735
Operating profit	36	81	73	56	65	118	137	165	183
Operating margin	26.1%	34.6%	28.3%	20.2%	19.8%	22.3%	24.1%	24.4%	24.9%
Other income	1	1	4	10	6	9	5	7	21
Interest	5	5	2	1	1	3	4	3	3
Depreciation	6	10	10	11	13	21	19	21	26
Profit before tax	19	68	66	54	57	102	119	145	170
Tax	12	20	15	10	10	21	35	34	44
Net profit	7	48	51	44	47	81	84	110	127

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	22	25	32	30	39	29	40	48	60	66	61	65	64	58	71	61	62	73	82	76	81	84	87	103	128	140	156	127	143	145	150	144	163	189	180	154	196	176	209	161	194	173
Operating profit	3	5	7	7	11	8	10	18	21	23	19	21	21	14	18	16	12	10	18	15	18	14	18	21	28	34	35	31	31	36	39	33	40	43	49	32	49	41	61	40	63	34
Operating margin	15.6%	22.2%	21.4%	24.2%	27.3%	27.0%	25.9%	38.4%	34.4%	34.9%	31.5%	32.3%	32.5%	23.6%	24.8%	26.0%	19.1%	13.9%	22.5%	19.2%	22.6%	17.0%	20.4%	20.2%	21.7%	24.1%	22.6%	24.2%	22.0%	24.7%	25.7%	22.7%	24.6%	22.9%	27.1%	20.8%	25.0%	23.4%	29.1%	24.6%	32.3%	19.4%
Other income	1	0	1	0	0	0	0	0	0	0	1	0	1	2	2	3	3	2	2	2	2	1	1	5	2	1	2	1	2	1	1	1	2	2	2	6	4	3	7	5	6	5
Interest	0	0	0	1	1	1	2	2	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0
Depreciation	1	1	1	1	1	1	2	2	2	2	3	2	3	3	3	3	3	3	3	3	3	3	3	5	5	5	5	5	4	5	5	5	5	6	5	6	6	7	7	7	7	8
Profit before tax	3	5	6	2	4	5	7	15	17	19	17	19	18	12	17	16	11	9	18	14	16	11	16	20	23	29	31	26	28	31	34	28	34	39	44	32	46	37	56	37	60	30
Tax	1	2	2	1	3	3	5	4	4	6	6	6	5	2	3	5	2	2	1	3	4	0	2	3	6	6	7	7	6	11	10	7	10	7	11	8	12	10	14	9	12	5
Net profit	3	3	4	1	1	2	2	11	13	13	11	13	13	10	13	11	9	8	16	11	13	11	13	17	18	23	23	19	22	20	24	21	24	32	33	24	33	27	42	28	48	24
EPS ₹	8.30	1.77	1.98	0.46	0.49	0.98	1.06	4.93	5.74	6.04	4.86	6.01	6.07	4.23	5.48	4.37	3.71	3.10	6.83	4.32	5.10	4.48	5.35	6.87	4.79	6.27	6.34	5.05	5.73	5.10	6.14	5.52	6.26	4.17	4.25	3.13	4.31	3.31	5.39	3.48	6.01	3.15
Revenue YoY	—	—	—	—	77.0%	17.7%	24.8%	58.1%	54.1%	126.9%	52.7%	34.4%	6.7%	-11.3%	16.2%	-5.9%	-2.1%	26.1%	15.4%	25.6%	29.3%	14.5%	6.1%	34.7%	58.1%	67.3%	80.0%	23.1%	12.3%	3.4%	-4.0%	13.5%	14.0%	30.1%	19.6%	7.4%	19.7%	-6.9%	16.2%	4.1%	-0.9%	-1.5%
Profit YoY	—	—	—	—	-62.5%	-29.6%	-44.5%	974.3%	1069.4%	516.2%	357.7%	22.0%	6.5%	-22.0%	25.6%	-19.1%	-32.3%	-26.8%	22.1%	-1.1%	37.5%	44.5%	-20.1%	59.0%	40.9%	110.2%	77.7%	13.1%	25.2%	-15.4%	1.0%	11.8%	9.3%	64.5%	39.3%	13.4%	37.5%	-14.9%	28.0%	15.5%	45.2%	-11.6%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 22 periods

	JUN '20	SEP '20	DEC '20	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	1.2%	0.3%	-1.8%	-1.8%	-0.8%	-0.4%	0.1%	0.0%	0.0%	1.4%	1.3%	1.3%	3.1%	1.8%	5.9%	9.8%	10.4%
ROCE	—	—	—	—	—	3.3%	2.5%	0.9%	1.6%	3.1%	4.3%	5.5%	6.7%	7.5%	7.9%	6.7%	7.2%	7.6%	8.2%	10.9%	12.0%	12.5%
Net margin	23.4%	18.4%	13.2%	5.3%	5.1%	1.9%	0.5%	-3.1%	-3.1%	-1.2%	-0.6%	0.1%	0.0%	0.0%	2.5%	2.5%	2.4%	5.7%	3.1%	9.9%	15.0%	15.6%
EBITDA margin	26.1%	26.5%	22.0%	17.8%	16.5%	13.3%	12.2%	9.7%	12.4%	16.2%	18.9%	21.2%	22.8%	24.3%	24.9%	24.6%	25.5%	26.6%	27.3%	28.2%	28.4%	27.8%
Debt / equity	—	—	—	—	—	0.45	0.45	0.45	0.45	0.48	0.48	0.52	0.52	0.21	0.21	0.25	0.25	0.24	0.24	0.25	0.25	0.24
Interest coverage	40.96	28.69	17.65	3.55	3.37	2.01	1.30	0.41	0.61	1.07	1.33	1.64	1.89	2.13	2.62	2.64	3.01	3.79	4.17	6.04	7.49	8.68
Asset turnover	—	—	—	—	—	0.38	0.38	0.36	0.36	0.37	0.37	0.37	0.38	0.39	0.40	0.39	0.40	0.38	0.41	0.42	0.45	0.45

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	9	9	9	9	10	10	10	20	20
Other equity / reserves	1,788	1,775	1,775	1,800	2,318	2,362	2,427	2,572	2,738
Total equity	1,797	1,783	1,783	1,809	2,328	2,372	2,437	2,591	2,758
Borrowings	802	796	864	936	491	586	591	658	664
Current liabilities	856	783	630	693	494	674	780	848	1,016
Non-current liabilities	339	345	599	600	304	273	276	266	363
Total assets	2,983	2,902	3,004	3,093	3,117	3,311	3,495	3,706	4,138
Property, plant & equipment	1,154	1,151	1,132	1,166	1,141	1,186	1,165	1,324	1,368
Capital work-in-progress	302	358	389	403	455	463	534	431	520
Investments	39	43	45	40	36	35	32	58	67
Inventories	364	320	332	345	327	348	445	367	443
Receivables	375	324	355	392	360	441	427	519	536
Cash & equivalents	47	21	24	30	17	26	18	41	45

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	105	226	135	132	342
Cash from investing	-286	-278	-167	-199	-326
Cash from financing	83	46	47	63	14
Capex	332	273	185	244	371
Free cash flow	-227	-46	-49	-111	-28
Dividends paid	9	10	0	0	10

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,368 cr33%

CWIP

₹520 cr13%

Investments

₹67 cr2%

Inventories

₹443 cr11%

Receivables

₹536 cr13%

Cash & equivalents

₹45 cr1%

Other assets

₹1,160 cr28%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Shilpa Medicare Limited	18,432	942.35	64.0	6.68	10.4%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-12.0%

6 months+113.3%

1 year+163.4%

3Y CAGR+71.2%

5Y CAGR+25.1%

10Y CAGR+11.7%

50-day avg₹960.98

200-day avg₹599.02

RSI (14)51

FAQs

What is the share price of Shilpa Medicare Limited?

Shilpa Medicare Limited (SHILPAMED) closed at ₹942.35 on NSE on 06 Nov 2026.

What is the market cap of Shilpa Medicare Limited?

₹18,432 crore at the latest close.

What is the P/E ratio of Shilpa Medicare Limited?

64.0, on trailing-twelve-month earnings from its filings.

How fast is Shilpa Medicare Limited growing?

Shilpa Medicare Limited: revenue has compounded at 13.6% a year over three years. Latest-quarter revenue is up 43.0% year on year, profit up 79.7%.

How profitable is Shilpa Medicare Limited?

On a trailing-twelve-month basis return on equity is 10.4%, return on capital employed 12.5%, operating margin 27.8%, net margin 15.6%.

How much debt does Shilpa Medicare Limited have?

Shilpa Medicare Limited is lightly geared: debt to equity is 0.24 with borrowings of ₹664 cr against cash of ₹45 cr (balance sheet of 2026-09-30). Operating profit covers interest 8.7 times.

Financials parsed from Shilpa Medicare Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.